Pharmaceuticals & Medical Devices HTS Classification Guide 2026: Chapter 30 & 90 Import Duties

Importing pharmaceuticals and medical devices into the United States requires navigating two regulatory systems simultaneously: CBP tariff classification under the HTS, and FDA product regulation. Misclassification in this sector carries uniquely severe penalties — not just retroactive duties, but potential FDA detention, refusal of admission, and destruction of product.

Chapter 30: Pharmaceutical Products

Chapter 30 covers medicines, vaccines, blood fractions, diagnostic reagents, and sterile medical supplies. Key headings:

• Heading 3002: Blood fractions, antisera, vaccines, toxins, cultures of microorganisms. Most products under 3002 qualify for duty-free treatment under the WTO Pharmaceutical Agreement.
• Heading 3003-3004: Medicaments — the critical distinction is whether the product is in measured doses or retail packaging (3004) or bulk/not put up for retail sale (3003).
• Heading 3005-3006: Wadding, gauze, bandages, and pharmaceutical preparations not elsewhere specified.

FDA registration note: All pharmaceutical imports require FDA establishment registration and drug listing. NDA/ANDA approval or OTC monograph compliance is required depending on the product category. Import Alert 66-40 (unapproved new drugs) is one of the most frequently triggered FDA import alerts.

Chapter 90: Medical Devices

Medical devices fall under Chapter 90 (optical, photographic, medical instruments). Key classification principles:

• Heading 9018: Medical, surgical, dental instruments — including syringes, needles, catheters, and surgical tools. Most qualify for duty-free treatment.
• Heading 9021: Orthopedic appliances — artificial joints, fracture fixation devices, hearing aids. Classification depends on function, not material.
• Heading 9022: X-ray, radiography apparatus. Subject to FDA CDRH radiation-emitting product regulations.

FDA device classification: All medical devices imported into the US must be cleared or approved by FDA CDRH. Class I devices (lowest risk) generally require only establishment registration and device listing. Class II devices require 510(k) premarket notification. Class III devices require PMA (Premarket Approval). The device classification is independent of HTS classification — both must be correct.

Section 301 Impact

Most pharmaceutical products and medical devices are excluded from Section 301 additional duties. The USTR specifically exempted 'pharmaceutical products, medicaments, and medical goods necessary to address the COVID-19 pandemic and other health emergencies.' However, certain medical consumables (gloves, gowns, masks under Chapter 39, 40, 62, 63) may be subject to Section 301 duties depending on country of origin.